Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection
Status of the E2007 (perampanel) Development Program
Signalife Announces Webcast
IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2008 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.